Albert Bourla, Pfizer CEO (Lintao Zhang/Getty Images)
October 13, 2023 05:35 PM EDTUpdated October 16, 10:22 AM
Pharma

Up­dat­ed: Pfiz­er plans $3.5B in cost cuts amid Covid slide, while Mod­er­na sticks by guid­ance

Drew Armstrong

Executive Editor

Pfiz­er will be­gin a com­pa­ny-wide cost-cut­ting pro­gram this year and next, part of a plan to bring the com­pa­ny’s costs in line with a world …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

In­side Iso­mor­phic Labs: Demis Has­s­abis’ lab-free vi­sion for biotech’s AI fu­ture

A service from the Financial Times